Ori Biotech
Ori Biotech is a London- and Philadelphia-based cell and gene therapy manufacturing technology company. Ori has developed a proprietary, flexible manufacturing platform that closes, automates and standardises manufacturing allowing therapeutics developers to further develop and bring their products from research stage through to patients. The mission of the Ori platform is to fully automate cell and gene therapy manufacturing to increase throughput, improve quality and decrease costs in order to enable patient access to this new generation of life-saving treatments. Founded by Dr. Farlan Veraitch and Professor Chris Mason in 2015, the team has over 80 years of pharmaceutical, cell therapy and venture building experience.
Amadeus contact
In the media
18th January 2022
Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
18th January 2022
Regenerative medicine – A phenomenal year for new therapies and distributed manufacturing
18th January 2022
Finding cures for cancer quicker - with Ori Biotech’s Jason C. Foster